Safety and effectiveness of gemcitabine for the treatment of classic Kaposi's sarcoma without visceral involvement.
Ther Adv Med Oncol
; 14: 17588359221086829, 2022.
Article
in En
| MEDLINE
| ID: mdl-35356263
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Ther Adv Med Oncol
Year:
2022
Type:
Article
Affiliation country:
Italy